<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SII-42245</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Adjuvant  Project</narrative>
  </title>
  <description type="2">
   <narrative xml:lang="EN">Given the Fund&apos;s focus on the late stage in the development of many of the drugs, vaccines and diagnostics in the pipeline, it is reasonable to expect a large development impact on several fronts: 
(i)	improving access to high-impact treatment for millions of patients, and especially vulnerable populations (children and pregnant women) 
(ii)	possible replication of the business model and scale-up of the flow of additional funding into late stage development of drugs for neglected diseases; 
(iii)	by demonstrating the commercial viability of the proposed funding structure, this could prove to be an important catalyst for the development of drugs that otherwise would not be developed</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">The proposed project entails an IFC equity commitment of up to US$20 million, not to exceed 20% of total commitments, in Adjuvant Global Health Technology Fund L.P. (The Fund), a 10-year closed-end fund raising US$200 million to make equity, mezzanine and debt investments in companies or projects developing solutions for overlooked public health challenges.</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, LP</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SII-42245" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-08-19" type="1"></activity-date>
  <activity-date iso-date="2019-09-03" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Adjuvant Global Health Technology Fund L.P.  Mr. Glenn Rockman  Founding Partner  +1 917 334 0724  gr@adjuvantcapital.com  501 5th Avenue, Suite 1404, New York, NY 10017  http://adjuvantcapital.com/about/</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN"></narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="XX" percentage="100">
   <narrative xml:lang="EN">World Region</narrative>
  </recipient-country>
  <location ref="XX-World Region">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">The Fund will invest in companies and/ or Product Development Partnerships globally, with an emphasis on markets and manufacturing hubs with strong life sciences network, who are advancing the development of promising solutions for infectious diseases that disproportionately affect developing countries. The General Partner and the Investment Advisor are domiciled in Delaware.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-20.0000000000 -40.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">other</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $25.00 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="510"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2019-08-19"></period-start>
   <period-end iso-date="2020-06-30"></period-end>
   <value currency="USD" value-date="2019-08-19">25000000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-08-19"></transaction-date>
   <value currency="USD" value-date="2019-08-19">25000000</value>
   <receiver-org>
    <narrative xml:lang="EN">ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, LP</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="510"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SII/42245/adjuvant-project">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information - Anticipated Impact Measurement &amp; Monitoring (AIMM) Assessment and Main Environmental &amp; Social Risks and Impacts of the Project</narrative>
   </title>
   <category code="A01"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SII/42245/adjuvant-project">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
